Star Combo Pharma Ltd Total Assets
Star Combo Pharma Ltd total assets. Based on the latest financial reports, Star Combo Pharma Ltd (S66) holds total assets worth AU$46.99 Million AUD (≈ $33.25 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Star Combo Pharma Ltd market cap and net worth for the company's overall valuation and market capitalisation.
Total Assets of Star Combo Pharma Ltd (2016–2025)
Total assets of Star Combo Pharma Ltd from 2016 to 2025. This chart illustrates how Star Combo Pharma Ltd's total assets have evolved over time, based on quarterly financial data. See Star Combo Pharma Ltd (S66) share price today for real-time trading data and today's change.
Star Combo Pharma Ltd - Asset Composition Analysis
Star Combo Pharma Ltd Total Assets Breakdown (June 2025)
Star Combo Pharma Ltd total assets breakdown as of June 2025. Star Combo Pharma Ltd's total assets of AU$46.99 Million consist of 53.2% current assets and 46.8% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 7.4% |
| Accounts Receivable | AU$2.03 Million | 4.2% |
| Inventory | AU$4.97 Million | 10.3% |
| Property, Plant & Equipment | AU$0.00 | 0.0% |
| Intangible Assets | AU$667.59K | 1.4% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how Star Combo Pharma Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital position of Star Combo Pharma Ltd to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Star Combo Pharma Ltd's current assets represent 53.2% of total assets in 2025, a decrease from 62.1% in 2016.
- Cash Position: Cash and equivalents constituted 7.4% of total assets in 2025, up from 2.3% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 10.3% of total assets.
Star Combo Pharma Ltd Competitors by Total Assets
Key competitors of Star Combo Pharma Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Taiyen Biotech Co Ltd
TW:1737
|
Taiwan | NT$8.38 Billion |
|
Delko S.A.
WAR:DEL
|
Poland | zł314.89 Million |
|
Rigolleau SA
BA:RIGO
|
Argentina | AR$154.64 Billion |
|
Mcphersons Ltd
AU:MCP
|
Australia | AU$116.49 Million |
|
ZOONO Group Ltd
AU:ZNO
|
Australia | AU$6.01 Million |
|
Skin Elements Ltd
AU:SKN
|
Australia | AU$2.01 Million |
|
Ontex Group NV
BR:ONTEX
|
Belgium | €2.16 Billion |
|
Natura &Co Holding S.A.
SA:NTCO3
|
Brazil | R$34.86 Billion |
Star Combo Pharma Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.64 | 3.80 | 9.29 |
| Quick Ratio | 5.63 | 2.95 | 7.71 |
| Cash Ratio | 0.00 | 2.50 | 1.63 |
| Working Capital | AU$20.82 Million | AU$14.46 Million | AU$25.45 Million |
Star Combo Pharma Ltd - Advanced Valuation Insights
This section examines the relationship between Star Combo Pharma Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.68 |
| Latest Market Cap to Assets Ratio | 0.30 |
| Asset Growth Rate (YoY) | 13.2% |
| Total Assets | AU$48.45 Million |
| Market Capitalization | $14.34 Million USD |
Valuation Analysis
Below Book Valuation: The market values Star Combo Pharma Ltd's assets below their book value (0.30x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Star Combo Pharma Ltd's assets grew by 13.2% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Star Combo Pharma Ltd (2016–2025)
The table below shows the annual total assets of Star Combo Pharma Ltd from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | AU$48.45 Million ≈ $34.28 Million |
+13.16% |
| 2024-06-30 | AU$42.82 Million ≈ $30.29 Million |
+1.39% |
| 2023-06-30 | AU$42.23 Million ≈ $29.88 Million |
-2.80% |
| 2022-06-30 | AU$43.44 Million ≈ $30.74 Million |
+0.28% |
| 2021-06-30 | AU$43.32 Million ≈ $30.65 Million |
-20.82% |
| 2020-06-30 | AU$54.72 Million ≈ $38.72 Million |
+98.93% |
| 2019-06-30 | AU$27.51 Million ≈ $19.46 Million |
+44.51% |
| 2018-06-30 | AU$19.03 Million ≈ $13.47 Million |
-1.46% |
| 2017-06-30 | AU$19.32 Million ≈ $13.67 Million |
+172.46% |
| 2016-06-30 | AU$7.09 Million ≈ $5.02 Million |
-- |
About Star Combo Pharma Ltd
Star Combo Pharma Limited manufactures and distributes health food products and nutritional supplements in Australia and China. It operates in two segments, OEM and Retail. The company develops, manufactures, markets, and sells natural health supplements and skin care products. It also provides its products through e-commerce platform to Chinese health product consumers. The company sells its pro… Read more